Carlos Bas

Hospital Alemán — Argentina

Medicine · Health Sciences

6h-index190citations23works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(6), Lung Cancer Treatments and Mutations(5), Lung Cancer Research Studies(5), Cancer Treatment and Pharmacology(4), Colorectal Cancer Treatments and Studies(3)

Publications23 total

[Primary hepatic sarcomatoid carcinoma, an unusual case].
PubMed·2024
Eficacia y seguridad de FOLFIRINOX vs. Gemcitabina + Nab-Paclitaxel (GemNab) en primera línea de tratamiento de cáncer de páncreas metastásico
Oncología Clínica·2022Open Access
[Bone pseudoprogression due to renal neoplasia during treatment with immune checkpoint inhibitors].
PubMed·2022· 1 cited
Efficacy and Safety of Nivolumab in Previously Treated Patients With Non–Small-cell Lung Cancer: Real World Experience in Argentina
Clinical Lung Cancer·2020· 23 cited
Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)
Thoracic Cancer·2019· 60 citedOpen Access
P2.25 Immunotherapy at Any Line of Treatment Improves Survival in Hispanic Patients with Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) Compared with Chemotherapy (Quijote-CLICaP)
Journal of Thoracic Oncology·2019
P2.23 Characterization of Hispanic Patients Who Experienced Hyperprogression During Treatment for Advanced NSCLC with Immunotherapy
Journal of Thoracic Oncology·2019
EP1.04-46 Immunotherapy at Any Line Improves Survival in Hispanic Patients with Advanced Metastatic NSCLC Compared to Chemotherapy (Quijote-CLICaP)
Journal of Thoracic Oncology·2019· 5 cited
Metastatic chordoma
JAAD Case Reports·2019· 3 citedOpen Access
P1.04-27 Safety of Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) in the Real-Life Setting: A Single-Institution Experience from Argentina
Journal of Thoracic Oncology·2018
P1.01-058 Real World Data with Nivolumab: Experience in Argentina
Journal of Thoracic Oncology·2017· 1 cited
Effect of age on completion of intraperitoneal chemotherapy in ovarian cancer
Annals of Oncology·2016Open Access
Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice
Oncotarget·2016· 38 citedOpen Access
Spinal cord compression secondary to metastasis of malignant chondroid syringoma: case report
Journal of Neurosurgery Spine·2015· 6 cited
Causes of discontinuation of intraperitoneal chemotherapy in patients with ovarian cancer.
Journal of Clinical Oncology·2012
Acalculous Cholecystitis in a Patient with Metastatic Renal Cell Carcinoma Treated with Sunitinib
Clinical Genitourinary Cancer·2009· 29 cited
Manifestaciones cutáneas de nuevas drogas oncológicas: inhibidores del receptor del factor de crecimiento epidérmico y prodrogas del 5-fluorouracilo.
2008· 2 cited
Cutaneous manifestations of new oncologic drugs: epidermal growth factor receptor inhibitors and 5-fl uorouracil prodrugs
2008· 3 cited
Variability among physicians on diagnosis and therapeutic approach of patients with Alzheimer disease plus cerebrovascular disease (ad+cvd)
European Psychiatry·2007
Irinotecan, Oxaliplatin Plus Bolus 5-Fluorouracil and Low Dose Folinic Acid Every 2 Weeks
American Journal of Clinical Oncology·2006· 7 cited
page 1 of 2Next →

Frequent Co-authors

Florencia Perazzo(7), Lorena Lupinacci(6), Omar Carranza(6), Manglio Rizzo(6), Alejandro Ruíz-Patiño(4), Óscar Arrieta(4), Andrés F. Cardona(4), Claudio Martín(4), Luis E. Raez(4), Feliciano Barrón(4), Luisa Ricaurte(4), M.A. Bravo-Garzón(4), Luís Más(4), Luis Corrales(4), Carmen Puparelli(4), Christian Rolfo(4), Pilar Archila(4), Carolina Sotelo(4), Hernán Carranza(4), Luís Pino(4)